Ignite Creation Date:
2024-05-06 @ 8:06 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06257550
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-06-05
First Post:
2024-02-05
Brief Title:
AdapTive Personalized Dietitian coacHing Messaging and pRoduce prescrIption to improVE Healthy Dietary Behaviors
Sponsor:
Johns Hopkins University
Organization:
Johns Hopkins University
Study Overview
Official Title:
THRIVE AdapTive Personalized Dietitian coacHing Messaging and pRoduce prescrIption to improVE Healthy Dietary Behaviors
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
THRIVE
Brief Summary:
THRIVE intervention is a 2-arm randomized pilot trial testing the feasibility and preliminary efficacy of producing prescriptions tailored dietitian counseling with adaptive messages and linkages to social resources among 60 Black adults with hypertension
Detailed Description:
Nearly 55 of Black adults have hypertension and uncontrolled blood pressure Dietary Approaches to Stop Hypertension DASH promotes a dietary pattern rich in fruits and vegetables fruits and vegetables low-fat dairy lean meats with reduced saturated fat and sweets which is effective in lowering blood pressure The proposed THRIVE intervention will enroll 60 Black adults with hypertension living in Healthy Food Priority Areas HFPAs in a 2-arm randomized pilot study One group will receive Produce prescriptions personalized dietitian coaching and adaptive bi-directional messaging the other group will receive standard produce bags Both groups will be linked to needed social services
The investigators will assess changes in overall DASH adherence acceptability and feasibility at 3- and 6-months post-randomization The investigators will 1 Develop and beta test THRIVE among Black adults with hypertension living in HFPAs 2 Test feasibility and preliminary efficacy of THRIVE at 6 12 weeks 3 Determine short-term sustainability of THRIVE at 6 months
The investigators will assess changes in overall DASH adherence acceptability and feasibility at 3- and 6-months post-randomization The investigators will 1 Develop and beta test THRIVE among Black adults with hypertension living in HFPAs 2 Test feasibility and preliminary efficacy of THRIVE at 6 12 weeks 3 Determine short-term sustainability of THRIVE at 6 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 24FIM1264121 | OTHER_GRANT | American Heart Association | None |